{
  "docId": "019dd923-622c-750b-8b9a-ad0811d3e80d",
  "docSlug": "dfcef8f28a20",
  "documentTitle": "Accelerate Diagnostics (AXDX)",
  "authorId": "61_White_Diamond_Research",
  "authorName": "White Diamond Research",
  "documentKindSlug": "research-note",
  "documentKindLabel": "Research note",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2019-09-16 00:00:00",
  "orientation": "portrait",
  "aspectRatio": 0.77272725,
  "pageNumber": 3,
  "pageCount": 41,
  "prevPage": 2,
  "nextPage": 4,
  "slideType": "expose_contradiction",
  "function": "expose_contradiction",
  "density": "dense",
  "nDataPoints": 4,
  "notes": "Includes a highlighted quote from a peer-reviewed article regarding the system's inability to replace standard of care.",
  "elementsJson": [
    "paragraph",
    "quote_block"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b9a-ad0811d3e80d/3",
  "deckHref": "/decks/019dd923-622c-750b-8b9a-ad0811d3e80d",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9a-ad0811d3e80d.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9a-ad0811d3e80d#slide-3",
  "components": [
    {
      "bbox": {
        "h": 0.051,
        "w": 0.764,
        "x": 0.118,
        "y": 0.705
      },
      "kind": "callout",
      "text": "This implies that the Accelerate Pheno system, as tested in this study, will not be able to replace the standard of care. It will rather serve as an adjunct to the standard of care.",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a6afc3e0-808b-4134-be5b-85de03c38e3f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.155,
        "w": 0.764,
        "x": 0.118,
        "y": 0.601
      },
      "kind": "paragraph",
      "text": "Another limitation of the system in our study was the high number of instances in which routine identification and AST were (not) recommended by the Accelerate Pheno system (26.8% of the time). This was because of technical failures (n = 21), indeterminate results (n = 36), or off-panel organisms that were not identified by the Accelerate Pheno system (n = 23). This implies that the Accelerate Pheno system, as tested in this study, will not be able to replace the standard of care. It will rather serve as an adjunct to the standard of care.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "dcb2737f-fe7e-4aa2-84c8-9274340c963e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.065,
        "w": 0.764,
        "x": 0.118,
        "y": 0.268
      },
      "kind": "paragraph",
      "text": "Mehren ended AXDX’s Q219 earnings call with: \"Thanks to our Board, who knows that we will be the standard of care and to our patient shareholders, thank you. We are on our way.\"",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "df0e45fd-6429-43ba-a8ad-759afc7b7ec6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.065,
        "w": 0.764,
        "x": 0.118,
        "y": 0.371
      },
      "kind": "paragraph",
      "text": "In this report we present a compelling argument both from our research and from published literature that Pheno system will not become the standard of care and will not replace the standard cell culture methods, despite Mehren’s claim.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f5acc6e8-5fb8-49f1-a62f-baeba87550ad",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "“Thanks to our Board, who knows that we will be the standard of care and to our patient shareholders, thank you. We are on our way.” — Mehren (AXDX CEO)",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd953-78b4-70ad-b39f-92686ce7bb25",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.045,
        "w": 0.764,
        "x": 0.118,
        "y": 0.198
      },
      "kind": "title",
      "text": "In sharp contrast to Accelerate’s claims, the Pheno is a niche product not designed to replace tissue culture methods",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a581fb94-dd25-4de8-9051-6eb53f992cb7",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "fraud-exposure",
      "slug": null,
      "matchId": "670fa5a8-71f1-492d-a2ef-70a7dc302366",
      "evidence": "Contrasting company claims with independent research findings to expose potential misrepresentation.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 9,
      "from": 3,
      "beatId": "c35db6aa-1659-4676-9230-380b8888605a",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Problem (Identify pain)",
      "beatSlug": "problem-agitate-solution-problem-identify-pain",
      "evidence": "The document highlights several issues with the Pheno system, including its narrow coverage of microorganisms and antibiotics, contamination risks, and the over-hyped criticality of AST testing for blood infection.",
      "position": 0,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}